IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2024 Holdings

Filed 2024-11-15 | 13 holdings | $33.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$22.0M113,50266.1%
Biontech SE(BNTX)COM09075V102$11.1M93,58333.4%
United Therapeutics Corp(UTHR)COM91307C102$36.0K100,3320.1%
Exelixis Inc(EXEL)COM30161Q104$33.3K1,281,6120.1%
Cardinal Health Inc(CAH)COM14149Y108$23.2K210,2630.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$15.5K1,498,0740.0%
Jazz Pharmaceuticals PLC(JAZZ)COMG50871105$12.3K110,2570.0%
Sanofi(SNY)COM80105N105$8.7K150,2050.0%
Alkermes PLC(ALKS)COMG01767105$7.0K251,4950.0%
Indivior PLC(INDV)COMG4766E116$6.8K701,8730.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$1.9K414,6840.0%
Regeneron Pharmaceuticals(REGN)COM75886F107$3713530.0%
Mural Oncology PLCCOMG63365103$23775,8680.0%